ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHELLE EISENBERG D.O.

Internal Medicine

1,369

$236K

154
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$172
Average prescription price

Avg: $67

JUAN SANCHEZ M.D.

Internal Medicine

378

$62.5K

63
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 27%

$165
Average prescription price

Avg: $67

SAVITHA SHASTRY M.D.

Internal Medicine

725

$117K

100
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 27%

$161
Average prescription price

Avg: $67

SOUAD YOUSSEF MD

Internal Medicine

7,330

$1.18M

294
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$161
Average prescription price

Avg: $67

PATRICIA SALVATO M.D.

Internal Medicine

28,382

$4.45M

908
256 are 65+

29%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$157
Average prescription price

Avg: $67

BINH NGUYEN MD

Internal Medicine

828

$129K

142
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$156
Average prescription price

Avg: $67

SYLVIA WU M.D.

Internal Medicine

1,478

$227K

86
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 27%

$153
Average prescription price

Avg: $67

GEORGE KEITH M.D.

Internal Medicine

7,172

$1.1M

533
459 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$153
Average prescription price

Avg: $67

TAPAN KADIA M.D.

Internal Medicine

564

$85.7K

70
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 27%

$152
Average prescription price

Avg: $67

NGUYEN TRAN D.O

Internal Medicine

8,217

$1.24M

410
347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 27%

$151
Average prescription price

Avg: $67

YASMIN MALDONADO M.D.

Internal Medicine

11,887

$1.76M

530
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$148
Average prescription price

Avg: $67

ALFREDO VAZQUEZ M.D.

Internal Medicine

432

$62.9K

73
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 27%

$146
Average prescription price

Avg: $67

NAMRATA SHARMA GOEL M.D.

Internal Medicine

2,641

$382K

243
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$145
Average prescription price

Avg: $67

UDAYA GAVINI MD

Internal Medicine

3,858

$555K

234
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 27%

$144
Average prescription price

Avg: $67

JOSEPHINE WIN M.D.

Internal Medicine

2,178

$305K

117
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$140
Average prescription price

Avg: $67

EUGENIO ARMENDARIZ MD

Internal Medicine

3,844

$530K

476
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 27%

$138
Average prescription price

Avg: $67

ROBERT GRIFFIN MD

Internal Medicine

2,840

$390K

62
15 are 65+

79%
patients receiving schedule two controlled substances

Avg: 1%

55%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $67

ALAN CORORVE M.D.

Internal Medicine

1,142

$157K

99
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $67

RICHARD LE M.D.

Internal Medicine

19,189

$2.62M

715
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $67

KIMBERLY KOENIG M.D.

Internal Medicine

274

$37.4K

51
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $67

MIHAELA SHUAIB MD

Internal Medicine

8,391

$1.14M

287
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 27%

$136
Average prescription price

Avg: $67

LADAN BAKHTARI M.D.

Internal Medicine

2,558

$345K

147
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$135
Average prescription price

Avg: $67

BROOKS TROTTER MD

Internal Medicine

3,833

$516K

241
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 27%

$135
Average prescription price

Avg: $67

GERARDO BUESO MD

Internal Medicine

7,194

$966K

552
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 27%

$134
Average prescription price

Avg: $67

SOCRATES GARRIGOS MD

Internal Medicine

5,982

$791K

299
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$132
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank